ACD Labs Logo

Articles & Third-Party References on ACD/Labs Software and Solutions

Recent journal articles and third-party references about ACD/Labs from the last year

Standardising Access to Data
Feb 28, 2020
S. Ktori (Laboratory informatics)
Sophia Ktori speaks with ACD/Labs' Andrew Anderson about helping lab users increase productivity through data standards and characterizing the interpretation of data.
Read Article

Innovative digital tools to enhance manufacturing performance
Feb 17, 2020
M. Parrish (Pharma Manufacturing)
In this article about digital tools that help organizations make data-driven manufacturing decisions, Meagan Parrish speaks to ACD/Labs Joe DiMartino about how Luminata helps organizations from early development through manufacturing.
Read Article

How Technology Has Changed The Role of an Analytical Chemist
Feb 07, 2020
R.J. Mackenzie (Technology Networks)
In this article Ruairi Mackenzie speaks with ACD/Labs' Andrew Anderson about Anderson's unique vantage point into how technology affects the analytical chemistry field. Read on for a discussion of how the day-to-day life of a chemist has been changed by technologies like AI and automation and how budding chemists can get their skillset up to scratch to handle the changing face of analytical science.
Read Article

Under the microscope: Mitigating risks in manufacturing processes
Feb 01, 2020
A. Anderson
In the light of recent media coverage about product recalls – particularly resulting from the detection and presence of NDMA – this article outlines ways to avoid the wide-ranging negative impacts on patients, pharmacies, manufacturers, pharmaceutical companies and health authorities and offers ways to mitigate the risk of future recalls.
Read article

NMR-Based Computer-Assisted Structure Elucidation (CASE) of Small Organic Molecules in Solution: Recent Advances
Sep 12, 2019
M. Elyashberg, D. Argyropoulos
CASE (computer‐assisted structure elucidation) first appeared in the late 1960s but really gained traction in the 1990s as more information‐rich 2D NMR experiments were developed. In this article, we discuss the strategies of CASE for small organic molecules in solution. Cognitive grounds and the principal CASE flow‐diagram, as well as the main obstacles impeding structure elucidation (presence of 'nonstandard' correlations and ambiguity of 2D NMR data, deficit of hydrogen, etc.) are discussed and methods to overcome these challenges are suggested. The methods are illustrated by examples of solving challenging problems. It has been shown that CASE can be used to avoid pitfalls during structure elucidation and to determine the most efficient combinations of 2D NMR experiments. Methodology of DFT‐based NMR spectrum prediction in synergistic combination with CASE is explained. The last advances in 3D structure elucidation and stereochemistry determination using RDCs and RCSAs are considered. In conclusions, perspectives of CASE development are discussed.
Read Article

Overcoming the Data Analysis Bottleneck in High-throughput Chemistry
Sep 02, 2019
R. Mackenzie (Technology Networks)
Technology Networks spoke with ACD/Labs' Andrew Anderson about how the field of biochemical research is being changed by automation and how our new product, Katalyst D2D, hopes to speed up pharmaceutical development.
Read more

ACD/Labs: Empowering Data-driven Decisions
Jun 26, 2019
This guide to informatics and data integrity published by the European Pharmaceutical Review highlights ACD/Labs software solutions including our Spectrus and Percepta platforms, and new solutions Luminata and Katalysts D2D.
Read more

Prediction of Human Lethality of Psychoactive Drugs From Rodent LD50 Values
Jun 01, 2019
J. Dearden (Liverpool John Moores University)
ACD/I-Lab was used to calculate mouse and rat LD50 values with impressive accuracy in this paper published in IJQSPR.
Read Article

To view all of our past articles and third-party references, please use our resource search.